FDA Continues Study of Direct-to-Consumer Television Advertising with Study of Corrective Advertising
On February 29, 2012, the Food & Drug Administration (FDA) issued a notice soliciting comments on its intent to conduct research entitled “Experimental Study: Examination of Corrective Direct-to-Consumer (DTC) Television Advertising.” FDA issued the notice pursuant to the Paperwork Reduction Act of 1995, which requires federal agencies interested in collecting information to first publish notice of the proposed collection of information in the Federal Register and grant the public sixty days to comment on the proposal. FDA’s proposed research will examine how corrective advertising may impact consumer misperceptions about drug product safety and efficacy. It also follows, FDA’s December 9, 2011, notice announcing its intent to collect information for a “Experimental Study of Comparative Direct-to-Consumer Advertising.”
Continue Reading...
Peter Swire, a professor at The Ohio State University Michael E. Moritz College of Law and a Senior Fellow with the Center for American Progress, opened the seminar with a keynote address that gave historical context to the most recent regulatory efforts addressing consumer privacy. Professor Swire’s remarks were followed by two panel sessions that included six experts representing key industry representatives and the federal agencies integral to recent privacy initiatives. The first panel discussed children's online privacy and the Federal Trade Commission’s proposed revisions to the Children's Online Privacy Protection Rule. The second panel discussed various consumer privacy enforcement and regulatory initiatives relating to mobile apps.
These apps can automatically collect a broad range of information, including a user's location, phone number, contacts, call logs, and unique identifiers. However, the report notes that neither the app stores nor app developers provide the information parents need to determine what data is collected from children or how it is shared.
